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PI3K: Downstream AKTion Minireview
Blocks Apoptosis
Thomas F. Franke,*† David R. Kaplan,* PtdIns-3,4,5-P3. There isevidence that PtdIns-3,4-P2can
also be synthesized by pathways that do not involveand Lewis C. Cantley†
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SH2 and PH domains interact with PtdIns-3,4,5-P3, butBoston, Massachusetts 02115
not with PtdIns-3,4-P2 (reviewed by Carpenter and Can-
tley, 1996), while the serine/threonine protein kinase Akt/
PKB is activated by PtdIns-3,4-P2 but not by PtdIns-Extracellular stimuli are transmitted intracellularly by
3,4,5-P3 (Franke et al., 1997; Klippel et al., 1997).signaling cascades that involve the interaction of macro-
Regulation of the Akt/PKB Kinase by PI3Kmolecules and/or the generation of second messenger
Akt/PKB is homologous to the PKA and PKC familiesmolecules that transduce signaling events over a dis-
of protein kinases (hence named PKB or Related to Atance between the origin and target of a signal. One
and C protein kinase: RAC-PK). It is also the cellularclass of such second messenger molecules isgenerated
homolog of the retroviral oncogenev-akt (see referencesvia phosphorylation of phosphoinositides on the D-3
in Burgering and Coffer, 1995; Cross et al., 1995; Frankeposition by phosphoinositide 3-kinase (PI3K). These
et al., 1995; Kohn et al., 1995). In vivo, the activity ofproducts of PI3K can act on multiple downstream ef-
Akt/PKB is regulated by serum and growth factors thatfectors that include Src homology-2 (SH2) and Pleckstrin
activate PI3K (Burgering and Coffer, 1995; Franke ethomology (PH) domains of serine/threonine and tyrosine
al., 1995, 1997; Kohn et al., 1995; Alessi et al., 1996;kinases and various cytoskeletal proteins (reviewed by
Andjelkovic et al., 1996). Three types of experimentsCarpenter and Cantley, 1996). The role of PI3K in intra-
have suggested that PI3K is necessary and sufficient forcellular signaling has been underscored by its implica-
growth factor-dependent activation of Akt. First, PDGFtion in a plethora of biological responses. Although it is
receptor mutants that are deficient in activating PI3Kunlikely that these multiple responses will be explained
fail to mediate activation of Akt/PKB (Burgering andby the action of a single downstream target, recent re-
Coffer, 1995; Franke et al., 1995). Second, dominant-search from several laboratories indicates that a signal-
inhibitory alleles of PI3K prevent activation of Akt (Burg-ing pathway from PI3K to the serine/threonine protein
ering and Coffer, 1995), and constitutively activatedkinase Akt/PKB may mediate some cellular responses
of PI3K (Burgering and Coffer, 1995; Cross et al., 1995;
Franke et al., 1995; Kohn et al., 1995), including protec-
tion from apoptosis (Dudek et al., 1997; Kauffmann-Zeh
et al., 1997; Khwaja et al., 1997; Kulik et al., 1997).
PI3K and Phosphoinositides
Multiple forms of PI3K withdistinct mechanisms of regula-
tion and different substrate specificities exist in mamma-
lian cells (reviewed by Carpenter and Cantley, 1996; Zvele-
bil et al., 1996). The various forms of PI3K are able to
phosphorylate the D-3 position of phosphatidylinositol
(PtdIns), phosphatidylinositol-4-phosphate (PtdIns-4-P),
and phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2)
to produce phosphatidylinositol-3-phosphate (PtdIns-
3-P), phosphatidylinositol-3,4-bisphosphate (PtdIns-
3,4-P2), and phosphatidylinositol-3,4,5-trisphosphate
(PtdIns-3,4,5-P3), respectively. PtdIns-3-P is constitu-
tively produced in the absence of growth factor stimula- Figure 1. Downstream Targets of Phosphoinositide 3-Kinases
tion and is implicated in vesicle trafficking. PtdIns-3, Various lipid kinases and phosphatases are involved in determining
the ratio of phosphoinositides in vivo. Several proteins specifically4-P2 and PtdIns-3,4,5-P3 are nominally absent in quies-
bind PtdIns-3,4-P2 and/or PtdIns-3,4,5-P3 in vitro. Among them arecent cells, but they appear acutely within seconds to
certain SH2 and PH domain–containing proteins that specificallyminutes of addition of extracellular stimuli and are ulti-
bind PtdIns-3,4,5-P3, including the p85 regulatory subunit of PI3Kmately degraded by phosphatases (Figure 1). In most
(reviewed by Carpenter and Cantley, 1996) and the Akt/PKB PH
cells that have been investigated, PtdIns-3,4-P2 appears domain that binds PtdIns-3,4-P2 (Franke et al., 1997). Several Ca21-
with a lag after the peak in PtdIns-3,4,5-P3, suggesting independent atypical PKC isoforms are activated by PtdIns-3,4-P2
and PtdIns-3,4,5-P3 (reviewed by Carpenter and Cantley, 1996).that it results from hydrolysis of the D-5 phosphate from
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PI3K increases Akt/PKB activity independent of growth able to phosphorylate one of these sites (serine 473) to
factor stimulation (Klippel et al., 1996; Marte et al., 1996; partially activate Akt/PKB in vitro (Alessi et al., 1996).
Franke et al., 1997). Third, the PI3K inhibitor wortmannin Since MAPKAP kinase 2 is activated by p38/HOG under
blocks activation of Akt/PKB by growth factors (Burger- conditions of cellular stress that do not activate PI3K,
ing and Coffer, 1995; Franke et al., 1995, 1997; Kohn et it may contribute to PI3K-independent activation of Akt/
al., 1995; Andjelkovic et al., 1996). Akt/PKB activation PKB in vivo (Alessi et al., 1996; Konishi et al., 1996). The
is partially dependent upon the activity of Ras (Franke kinase that phosphorylates Akt/PKB in its catalytic loop
et al., 1995), and activated mutants of R-Ras and Ras on threonine 308 and activates Akt/PKB in the growth
may stimulate Akt/PKB by activating PI3K (Klippel et al., factor- and PI3K-dependent pathway is not known.
1996; Marte et al., 1996). Although these studies indicate Akt/PKB as a Direct Effector of PI3K
that PI3K is necessary to activate this enzyme in re- A direct mechanism of Akt/PKB activation by PI3K that
sponse to certain extracellular stimuli, an additional involves the binding of PtdIns-3,4-P2 to the Akt/PKB PH
pathway for activation has been suggested that is inde- domain has been described recently (Franke et al., 1997;
pendent of PI3K and could involve p38/HOG (Alessi et Klippel et al., 1997). PtdIns-3,4,5-P3 does not activate
al., 1996; Konishi et al., 1996). The diversity of factors Akt/PKB and may cause some inhibition of the basal
leading to the activation of Akt/PKB may explain the activity. The failure of the structural isomer PtdIns-4,5-
existence of conflicting models of Akt/PKB regulation. P2 to activate Akt/PKB supports the view that the activa-
Akt/PKB molecules are ableto dimerize and to interact tion of Akt/PKB by PtdIns-3,4-P2 is physiologically rele-
with other proteins through an NH2-terminal region that vant. PtdIns-3,4-P2 causes dimerization of Akt/PKB,
includes a PH domain (Konishi et al., 1996; Franke et which could be the mechanism of activation (Franke et
al., 1997, and references therein). Homo-oligomerization al., 1997). These results suggest the model presented
of Akt/PKB is induced by interaction with PtdIns-3,4-P2 in Figure 2. Activation of PI3K by growth factors results
and increases Akt/PKB activity (Franke et al., 1997); in the production of PtdIns-3,4-P2 at the membrane. Akt/
homo-oligomerization is also involved in the regulation PKB binds to this lipid, dimerizes, and is stabilized in a
of the serine/threonine kinase Raf and could possibly be partially active state. The location at the membrane and/
a general mechanism of regulation of serine/threonine
or the dimerization then enhances the ability of Akt/PKB
kinases that will have to be examined further (reviewed
to be phosphorylated.
by Marshall, 1996). The integrity of the NH2-terminal PH Although Ras is involved in activation of Akt/PKB
domain is required for in vivo activation of Akt/PKB by
(Franke et al., 1995; Klippel et al., 1996; Marte et al.,several growth factors, by constitutively activePI3K, and
1996), Akt/PKB does not appear to be in the pathwayalso by certain pathways independent of PI3K (Franke et
leading to the activation of MAPK (Franke et al., 1995).al., 1995, 1997; Andjelkovic et al., 1996; Klippel et al.,
This is consistent with the fact that R-Ras activates Akt/1996; Konishi et al., 1996). In contrast, the Akt/PKB PH
PKB but does not activate MAPK (Marte et al., 1996).domain is not required for Akt/PKBactivation by okadaic
These results indicate the existence of a Ras signalingacid or insulin in cells overexpressing the insulin recep-
cascade parallel to the Raf/MEK/MAPK pathway: Rastor (Kohn et al., 1995; Andjelkovic et al., 1996). These
binds and activates PI3K, causing activation of Akt/PKB.results indicate that the relative importance of the Akt/
The only known protein target of Akt/PKB is glycogenPKB PH domain for activation depends on the cell type
synthase kinase-3 (GSK3): Akt/PKB phosphorylatesor the stimulus used.
N-terminal sequences in GSK3 in vitro that are importantTreatment of cells with inhibitors of serine/threonine
for GSK3 inhibition by insulin stimulation in vivo, therebyphosphatases and direct treatment of purified Akt/PKB
linking PI3K and Akt/PKBto insulin-dependent glycogenwith phosphatases has shown that Akt/PKB phosphory-
synthesis (Cross et al., 1995). There is also evidencelation is critical for its activity. The major phosphoryla-
that p70S6kinase is downstream of constitutively activatedtion sites required for activation have been identified as
threonine 308 and serine 473, and MAPKAP kinase 2 is Akt/PKB (Burgering and Coffer, 1995).
Figure 2. Akt/PKB Is an Effector of PI3K In
Vivo
Akt/PKB is activated by growth factors that
stimulate PI3K. Akt/PKB activity is regulated
by PtdIns-3,4-P2 (Franke et al., 1997; Klippel
et al., 1997) as well as by phosphorylation on
serine and threonine residues (Alessi et al.,
1996) that may stabilize a transiently induced
conformational change. Akt/PKB participates
in the regulation of p70S6kinase (Burgering and
Coffer, 1995), but is not sufficient for MAPK
activation (Franke et al., 1995). GSK3 is the
first identified direct target of Akt/PKB (Cross
et al., 1995). One prominent biological role of
Akt/PKB is the PI3K-dependent regulation of
survival (Dudek et al., 1997; Kauffmann-Zeh




PI3K, Akt/PKB, and Cell Survival undetermined; future studies will address whether Akt/
PKB mediates survival by phosphorylation and inhibitionExciting insights into the function of Akt/PKB have been
revealed by studies investigating its function in PI3K- of proteins that are involved in programmed cell death.
The observation that PI3K and Akt/PKB are involved independent pathways that are involved in the regulation
of cell survival. Previous studieshave demonstrated that cell survival certainly could explain why so many onco-
proteins, growth factors, and survival factors havePI3K is involved in serum-dependent survival of PC12
cells (reviewed by Carpenter and Cantley, 1996). Recent evolved mechanisms for activation of PI3K.
results indicate that PI3K also mediates type 1 insulin-
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Many groups are currently extending these findings Note Added in Proof
and contributing to the further understanding of Akt/
PKB in survival in other cell systems. GSK3 has not been While this minireview was in the proof stages, we learned that S. G.
Kennedy, A. J. Wagner, S. D. Conzen, J. Jorda´n, A. Bellacosa, P. N.implicated in the regulation of survival (see references
Tsichlis, and N. Hay had obtained results ([1997] Genes Dev., inin Kauffmann-Zeh et al., 1997), suggesting that Akt/PKB
press), similar to those of Kaufmann-Zeh et al. (1997), demonstratinghas more widespread roles in cell regulation and em-
that activated Akt will suppress apoptosis that is induced by serumploys distinct subsets of substrates in different signaling
withdrawal and ectopic expression of myc in Rat-1 fibroblasts.
systems. Additional direct downstream targets of Akt/
PKB other than GSK3 must exist that have not been
identified. Recent studies have provided some insight
into the mechanism by which cell survival factors cause
modifications to members of the Bcl-2 family of proteins
(reviewed by Gajewski and Thompson, 1996). The exact
mechanisms of prevention of apoptosis by Akt/PKB are
